Daniel Faensen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Daniel Faensen has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Annika Hinze
University of Waikato, Hamilton, New Zealand
3 shared publications Doris Altmann
Abteilung Epidemiologie für Infektiöse Erkrankungen, Robert Koch-Institut, Berlin, Germany
2 shared publicationsAndrea Ammon
Robert Koch Institute, Berlin, Germany; †Picoware GmbH, Berlin, GermanyCurrent affiliation: European Centre for Disease Prevention and Control, Stockholm, Sweden
1 shared publication- Andrea Ammon
European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
1 shared publication Brunhilde Schweiger
Nationales Referenzzentrum für Influenza, Robert Koch-Institut, Berlin, Germany
1 shared publicationCarina Helmeke
Fachbereich Hygiene, Landesamt für Verbraucherschutz, Magdeburg, Germany
1 shared publication
Latest Publications
- Open Access
- 18 July 2011
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (7) , e19932
Effectiveness of the AS03-Adjuvanted Vaccine against Pandemic Influenza Virus A/(H1N1) 2009 – A Comparison of Two Methods; Germany, 2009/10
During the autumn wave of the pandemic influenza virus A/(H1N1) 2009 (pIV) the German population was offered an AS03-adjuvanted vaccine. The authors compared results of two methods calculating the effectiveness of the vaccine (VE). The test-negative case-control method used data from virologic surveillance including influenza-positive and negative patients. An innovative case-series methodology explored data from all nationally reported laboratory-confirmed influenza cases. The proportion of reported cases occurring in vaccinees during an assumed unprotected phase after vaccination was compared with that occurring in vaccinees during their assumed protected phase. The test-negative case-control method included 1,749 pIV cases and 2,087 influenza test-negative individuals of whom 6 (0.3%) and 36 (1.7%), respectively, were vaccinated. The case series method included data from 73,280 cases. VE in the two methods was 79% (95% confidence interval (CI) = 35–93%; P = 0.007) and 87% (95% CI = 78–92%; P<0.001) for individuals less than 14 years of age and 70% (95% CI = −45%–94%, P = 0.13) and 74% (95% CI = 64–82%; P<0.001) for individuals above the age of 14. Both methods yielded similar VE in both age groups; and VE for the younger age group seemed to be higher.
- 18 July 2011
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (7) , e19932
Open AccessEffectiveness of the AS03-Adjuvanted Vaccine against Pandemic Influenza Virus A/(H1N1) 2009 – A Comparison of Two Methods; Germany, 2009/10
During the autumn wave of the pandemic influenza virus A/(H1N1) 2009 (pIV) the German population was offered an AS03-adjuvanted vaccine. The authors compared results of two methods calculating the effectiveness of the vaccine (VE). The test-negative case-control method used data from virologic surveillance including influenza-positive and negative patients. An innovative case-series methodology explored data from all nationally reported laboratory-confirmed influenza cases. The proportion of reported cases occurring in vaccinees during an assumed unprotected phase after vaccination was compared with that occurring in vaccinees during their assumed protected phase. The test-negative case-control method included 1,749 pIV cases and 2,087 influenza test-negative individuals of whom 6 (0.3%) and 36 (1.7%), respectively, were vaccinated. The case series method included data from 73,280 cases. VE in the two methods was 79% (95% confidence interval (CI) = 35–93%; P = 0.007) and 87% (95% CI = 78–92%; P<0.001) for individuals less than 14 years of age and 70% (95% CI = −45%–94%, P = 0.13) and 74% (95% CI = 64–82%; P<0.001) for individuals above the age of 14. Both methods yielded similar VE in both age groups; and VE for the younger age group seemed to be higher.
- 6 February 2009
- Published by Springer Nature in Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
- Vol. 52 (2) , 176-182
Surveillance von Infektionskrankheiten auf europäischer Ebene
Mit der im Jahr 1998 von EU-Parlament und Ministerrat getroffenen Entscheidung zur Etablierung eines EU-weiten Netzwerks zur Überwachung von Infektionskrankheiten wurde die Grundlage für die EUweite Surveillance geschaffen. Seit Mai 2005 hat das Europäische Zentrum für die Prävention und die Kontrolle von Krankheiten (ECDC) die Aufgabe, dieses Netzwerk zu koordinieren und weiterzuentwickeln. Eine der Hauptfunktionen des ECDC besteht darin, die europäische Infektionsüberwachung zu standardisieren und insbesondere die Verfahrensweisen der weitgehend voneinander unabhängigen Surveillance-Netzwerke zu vereinheitlichen. Als einer der ersten Schritte wurden in Zusammenarbeit mit den Mitgliedsstaaten die EU-Falldefinitionen für die Surveillance revidiert. Die Surveillance-Netzwerke werden derzeit nach einem standardisierten Protokoll evaluiert, bevor im ECDC eine Entscheidung über die Zukunft der einzelnen Netzwerkaktivitäten getroffen wird. Parallel wurde mit der Entwicklung eines einheitlichen Datenerfassungssystems (The European Surveillance System, TESSy) begonnen. Seit Beginn 2008 werden die Nutzer spezifisch geschult. TESSy ist seit April 2008 funktionsfähig. Zukünftig muss das Hauptaugenmerk auf die Qualität und Vergleichbarkeit der Daten gerichtet sein, da nur valide und vergleichbare Daten eine gute Grundlage für Entscheidungen im Gesundheitsbereich sind. The basis for EU wide surveillance was Decision 2119/98/EC of the European Parliament and the Council in 1998. Since May 2005 it is the task of the European Centre for Disease Prevention and Control to coordinate and further develop this network. One key function of the ECDC is to standardise European surveillance and especially to harmonise the procedures of the surveillance networks that developed independently of each other. As a first step, the EU case definitions have been revised jointly with the Member States and the Commission. All surveillance networks are evaluated with a standard protocol before a decision is made at the ECDC on the continuation of the individual network activities. Simultaneously, the development of The European Surveillance System (TESSy) progressed. Since the beginning of 2008 data users have been trained and TESSy has been in use since April 2008. In the future the main focus must be the improvement of the quality and comparability of the data as such data are the essential prerequisite for decision making in public health.
- 6 February 2009
- Published by Springer Nature in Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
- Vol. 52 (2) , 176-182
Surveillance von Infektionskrankheiten auf europäischer Ebene
Mit der im Jahr 1998 von EU-Parlament und Ministerrat getroffenen Entscheidung zur Etablierung eines EU-weiten Netzwerks zur Überwachung von Infektionskrankheiten wurde die Grundlage für die EUweite Surveillance geschaffen. Seit Mai 2005 hat das Europäische Zentrum für die Prävention und die Kontrolle von Krankheiten (ECDC) die Aufgabe, dieses Netzwerk zu koordinieren und weiterzuentwickeln. Eine der Hauptfunktionen des ECDC besteht darin, die europäische Infektionsüberwachung zu standardisieren und insbesondere die Verfahrensweisen der weitgehend voneinander unabhängigen Surveillance-Netzwerke zu vereinheitlichen. Als einer der ersten Schritte wurden in Zusammenarbeit mit den Mitgliedsstaaten die EU-Falldefinitionen für die Surveillance revidiert. Die Surveillance-Netzwerke werden derzeit nach einem standardisierten Protokoll evaluiert, bevor im ECDC eine Entscheidung über die Zukunft der einzelnen Netzwerkaktivitäten getroffen wird. Parallel wurde mit der Entwicklung eines einheitlichen Datenerfassungssystems (The European Surveillance System, TESSy) begonnen. Seit Beginn 2008 werden die Nutzer spezifisch geschult. TESSy ist seit April 2008 funktionsfähig. Zukünftig muss das Hauptaugenmerk auf die Qualität und Vergleichbarkeit der Daten gerichtet sein, da nur valide und vergleichbare Daten eine gute Grundlage für Entscheidungen im Gesundheitsbereich sind. The basis for EU wide surveillance was Decision 2119/98/EC of the European Parliament and the Council in 1998. Since May 2005 it is the task of the European Centre for Disease Prevention and Control to coordinate and further develop this network. One key function of the ECDC is to standardise European surveillance and especially to harmonise the procedures of the surveillance networks that developed independently of each other. As a first step, the EU case definitions have been revised jointly with the Member States and the Commission. All surveillance networks are evaluated with a standard protocol before a decision is made at the ECDC on the continuation of the individual network activities. Simultaneously, the development of The European Surveillance System (TESSy) progressed. Since the beginning of 2008 data users have been trained and TESSy has been in use since April 2008. In the future the main focus must be the improvement of the quality and comparability of the data as such data are the essential prerequisite for decision making in public health.
- Open Access
- 1 October 2007
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 13 (10) , 1548-1555
SurvNet Electronic Surveillance System for Infectious Disease Outbreaks, Germany
In 2001, the Robert Koch Institute (RKI) implemented a new electronic surveillance system (SurvNet) for infectious disease outbreaks in Germany. SurvNet has captured 30,578 outbreak reports in 2001–2005. The size of the outbreaks ranged from 2 to 527 cases. For outbreaks reported in 2002–2005, the median duration from notification of the first case to the local health department until receipt of the outbreak report at RKI was 7 days. Median outbreak duration ranged from 1 day (caused by Campylobacter) up to 73 days (caused by Mycobacterium tuberculosis). The most common settings among the 10,008 entries for 9,946 outbreaks in 2004 and 2005 were households (5,262; 53%), nursing homes (1,218; 12%), and hospitals (1,248; 12%). SurvNet may be a useful tool for other outbreak surveillance systems because it minimizes the workload of local health departments and captures outbreaks even when causative pathogens have not yet been identified.
- 1 October 2007
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 13 (10) , 1548-1555
Open AccessSurvNet Electronic Surveillance System for Infectious Disease Outbreaks, Germany
In 2001, the Robert Koch Institute (RKI) implemented a new electronic surveillance system (SurvNet) for infectious disease outbreaks in Germany. SurvNet has captured 30,578 outbreak reports in 2001–2005. The size of the outbreaks ranged from 2 to 527 cases. For outbreaks reported in 2002–2005, the median duration from notification of the first case to the local health department until receipt of the outbreak report at RKI was 7 days. Median outbreak duration ranged from 1 day (caused by Campylobacter) up to 73 days (caused by Mycobacterium tuberculosis). The most common settings among the 10,008 entries for 9,946 outbreaks in 2004 and 2005 were households (5,262; 53%), nursing homes (1,218; 12%), and hospitals (1,248; 12%). SurvNet may be a useful tool for other outbreak surveillance systems because it minimizes the workload of local health departments and captures outbreaks even when causative pathogens have not yet been identified.
- 1 January 2000
- Published by Springer Nature
- p. 21-22
Database Systems as Middleware - Events, Notifications, Messages
- 1 January 2000
- Published by Springer Nature
- p. 21-22
Database Systems as Middleware - Events, Notifications, Messages
- 1 July 1999
- Published by Elsevier in International Journal of Insect Morphology and Embryology
- Vol. 28 (3) , 203-210
Neurons with dopamine-like immunoreactivity target mushroom body Kenyon cell somata in the brain of some hymenopteran insects
- 1 July 1999
- Published by Elsevier in International Journal of Insect Morphology and Embryology
- Vol. 28 (3) , 203-210
Neurons with dopamine-like immunoreactivity target mushroom body Kenyon cell somata in the brain of some hymenopteran insects
- 1 January 1999
- Published by Springer Nature in Lecture Notes in Computer Science
- p. 284-293
A Unified Model of Internet Scale Alerting Services
- 1 January 1999
- Published by Springer Nature in Lecture Notes in Computer Science
- p. 284-293
A Unified Model of Internet Scale Alerting Services
- 1 January 1998
- Published by Springer Nature in Lecture Notes in Computer Science
- p. 643-644
Alerting in a Digital Library Environment Do Channels Meet the Requirements?
- 1 January 1998
- Published by Springer Nature in Lecture Notes in Computer Science
- p. 643-644
Alerting in a Digital Library Environment Do Channels Meet the Requirements?